This ADC product is comprised of an anti-CD22 monoclonal antibody conjugated (clone hLL2) via a linker to SN-38. The SN-38 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the c
* VAT and and shipping costs not included. Errors and price changes excepted